biopharma

GE Stock Surges on News of Biopharma Sale
Turnarounds

GE Stock Surges on News of Biopharma Sale

The $21 billion sale to Danaher is a "pivotal milestone" in GE's plan to reduce debt and strengthen its balance sheet, CEO Larry Culp says.
By Matthew Heller | February 25, 2019
Read More
LabCorp Buys U.K. Biopharma Services Firm
Strategy

LabCorp Buys U.K. Biopharma Services Firm

The $1.2 billion acquisition of Chiltern continues a wave of consolidation in the contract research organization industry.
By Matthew Heller | July 31, 2017
Read More
Thermo Fisher Moves Into Drug Manufacturing
Strategy

Thermo Fisher Moves Into Drug Manufacturing

The $5.2 billion acquisition of Patheon positions Thermo Fisher to grab a slice of the fast-growing contract drug production business.
By Matthew Heller | May 15, 2017
Read More
Puma Biotech Exec Accused of Insider Trading
Risk & Compliance

Puma Biotech Exec Accused of Insider Trading

Robert Gadimian allegedly made $1.1 million by trading on nonpublic information he learned about Puma's breast cancer drug trials.
By Matthew Heller | September 30, 2016
Read More
Thermo Fisher Makes Electron Microscopy Move
Technology

Thermo Fisher Makes Electron Microscopy Move

The lab equipment firm's $4.2 billion purchase of FEI gives it access to technology used by biopharma companies to develop drugs.
By Matthew Heller | May 30, 2016
Read More